7 Jul 21
7 Jul 21
Biocomposites announces new approval for STIMULAN® to treat bacterial infection
STIMULAN® when mixed with antibiotics is the only calcium matrix approved for treating bacterial infection
Keele, UK, 7 July 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets…...
Catch up on our webinar

Management of the Infected Diabetic Foot

Prof. Venu Kavarthapu

Biofilm series

Professor Paul Stoodley answers some of the common questions surrounding the causes, impact and treatment of biofilm.


The only calcium matrix approved for mixing with vancomycin, gentamicin and tobramycin for use in bone and soft tissue.

30 Mar 21
30 Mar 21
Biocomposites Launches Biocomposites Companion
An app that puts critical user information in the hands of healthcare professionals to ensure they harness the power of STIMULAN and genex in their surgical procedures
Keele, UK, 30 March 2021 – Biocomposites, an international medical device company that engineers, manufactures and…...
Explore our library

Our industry leading knowledge, dedication and experience is supported with over 400 peer
reviewed papers, presentations and posters.

23 Apr 20
23 Apr 20
Biocomposites announces new CE Mark for STIMULAN®
First calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue
Keele, UK, 23 April 2020 – Biocomposites, an international medical devices company that engineers, manufactures and…...
Pioneering calcium compounds

Innovation is at the very heart of what we do, resulting in over 100 grants and registrations.

Your specialty

Access case studies, clinical and pre-clinical papers for musculoskeletal infection, trauma and spine to see how we are innovating across a wide range of clinical applications to help surgeons and their patients.

Musculoskeletal infections

Musculoskeletal infections, including infected non-unions, osteomyelitis and periprosthetic joint infections, are one of the biggest healthcare challenges of the 21st century.

As the rapid growth of antibiotic-resistant strains and biofilms continues to outpace the development of new antibiotics and antibiotic strategies, care delivery is becoming increasingly challenging and complicated.


The popularity of spine surgery differs around the world. The number of procedures performed in the USA is double the number performed in Western Europe, Canada and Australia combined, and five times the number in the UK.

In the USA, the number of spinal fusion procedures increased by 64% between 2002 and 2014, from approximately 268,000 to 414,000. The average cost per procedure has increased from $15,868 to $28,954 over the same period and was more than $12 billion in total in 2014.

Why Biocomposites?

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 30 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

  • Singular focus
  • Proprietary technology
  • Dedicated to quality
Learn more